Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour.
A recombinant antigen vaccine against Schistosoma mansoni remains elusive, in part because the parasite deploys complex defensive and offensive strategies to combat immune attack. Nevertheless, research on rodent and primate models has shown that schistosomes can be defeated when appropriate responses are elicited. Acquired protection appears to involve protracted inhibition of larval migration or key molecular processes at the adult surfaces, not rapid cytolytic killing mechanisms. A successful vaccine will likely require a cocktail of antigens rather than a single recombinant protein. In addition, ways need to be found of keeping the immune system on permanent alert, either to achieve adequate inhibition of protein function in adults, or because a trickle of incoming parasites does not amplify the secondary response.
Wilson
R Alan
RA
Department of Biology, University of York, PO Box 373,York YO10 5YW, UK. raw3@york.ac.uk
Coulson
Patricia S
PS
D000818:Animals; D000947:Antigens, Helminth / Q000276:immunology; D006790:Host-Parasite Interactions; D006801:Humans; D007814:Larva / Q000502:physiology; D008253:Macaca mulatta / Q000469:parasitology; D051379:Mice / Q000469:parasitology; D012550:Schistosoma mansoni / Q000254:growth & development / Q000276:immunology* / Q000502:physiology; D012555:Schistosomiasis mansoni / Q000276:immunology / Q000517:prevention & control*; D014612:Vaccines / Q000008:administration & dosage / Q000276:immunology
D000947:Antigens, Helminth; D014612:Vaccines